Internal Medicine, Endocrinology, Diabetes, & Metabolism · Anderson, IN
NPI
1306839030
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
141 W 22nd St Ste 210
Anderson, IN, 46016
Phone (765) 646-8795
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
1,758 services
Medicare patients, 2024
399
Average age 72
Drug cost, 2024
$6.9M
13,905 prescriptions
Company payments, 2025
$33.06
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmed F Al Jebawi was code 99214 (office e&m - established), 479 times for 327 patients. In total Ahmed F Al Jebawi billed 1,758 services in 17 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 479 | 327 | $81.87 | $39K |
| 82962 Clinical Chemistry | Office | 458 | 292 | $3.17 | $1,451 |
| 83036 Blood Count | Office | 409 | 274 | $9.41 | $3,847 |
| 95251 Test - Miscellaneous | Office | 144 | 97 | $23.56 | $3,393 |
| 99213 Office E&M - Established | Office | 75 | 67 | $56.37 | $4,228 |
| 82044 Clinical Chemistry | Office | 38 | 38 | $5.95 | $226 |
| 99204 Office E&M - New | Office | 38 | 38 | $100.72 | $3,827 |
| 95249 Test - Miscellaneous | Office | 13 | 13 | $46.65 | $606 |
By year: 2022 $94K for 2,658 services; 2023 $71K for 2,095 services; 2024 $59K for 1,758 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 458 | 292 | $3.17 | $1,451 |
| 83036 Blood Count | 409 | 274 | $9.41 | $3,847 |
| 82044 Clinical Chemistry | 38 | 38 | $5.95 | $226 |
Medicare prescription drug claims, 2024
In 2024, the drug Ahmed F Al Jebawi prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,152 prescriptions and refills. In total Ahmed F Al Jebawi wrote 13,905 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,152 | 1,853 | 252 | $1.8M |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 872 | 1,967 | 255 | $152K |
| Levothyroxine Sodium Generic | 848 | 2,084 | 209 | $11K |
| Atorvastatin Calcium Generic | 822 | 2,202 | 251 | $8,690 |
| Metformin Hcl Er Metformin Hcl | 558 | 1,342 | 160 | $4,874 |
| Mounjaro Tirzepatide | 491 | 644 | 91 | $683K |
| Jardiance Empagliflozin | 472 | 946 | 112 | $547K |
| Humalog Kwikpen U-100 Insulin Lispro | 430 | 971 | 155 | $204K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 346 | 770 | 141 | $33K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 308 | 800 | 88 | $3,177 |
| Losartan Potassium Generic | 281 | 764 | 91 | $2,514 |
| Novolog Flexpen Insulin Aspart | 273 | 442 | 90 | $88K |
| Trulicity Dulaglutide | 259 | 381 | 61 | $370K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 245 | 356 | 65 | $76K |
| Pioglitazone Hcl Generic | 245 | 657 | 70 | $2,426 |
Brand drugs: 6,884 claims; generic drugs: 5,667 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmed F Al Jebawi $33.06 ($33.06 in general payments such as food, travel and fees) from 1 company. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $33.06.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $33.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.